Descriptive epidemiology of hepatitis C virus among male heroin abusers in Taiwan

Southern Medical Journal

Volumn 99, Issue 4, 2006, Pages 348-351

  Liao, Kuan Fu ^b   Peng, Chen Yuang ^b   Lai, Shih Wei ^a   Chang, Wu Long ^b   Hsu, Nan Yung ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

Epidemiology; Hepatitis C; Heroin abuser; Needle sharing; Prevalence; Tattoo

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRISONER; SEROPREVALENCE; TAIWAN; TATTOOING;

ADULT; AGE DISTRIBUTION; AGED; CROSS-SECTIONAL STUDIES; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PRISONERS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN;

EID: 33646490276     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000209284.33650.45     Document Type: Article

References (22)

1. Main Causes of Deaths in Taiwan in 2002, Department of Health, Taiwan. Available at: http://www.doh.gov.tw/ufile/Doc/S02/9101-eng.xls. Accessed February 23, 2006.
2. Chen DS, Wang JT, Chen PJ, et al. Hepatitis C virus infection in Taiwan. Gastroenterol Jpn 1991;26(suppl 3):164-166.
3. Tsai JF, Chang WY, Jeng JE, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993;41:296-300.
4. Tai DI, Chen CH, Chang TT, et al. Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection. J Gastroenterol Hepatol 2002;17:682-689.
5. Chen TZ, Wu JC, Yen FS, et al. Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Med Virol 1995;46:247-251.
6. Li CP, Hwang SJ, Lu CL, et al. Risk factor analysis of patients with chronic hepatitis C in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 1996;58:275-280.
7. Wang CS, Chang TT, Chou P. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan. J Clin Epidemiol 1998;51:733-738.
8. Chang CJ, Ko YC, Liu HW. Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan. J Formos Med Assoc 1998;97:826-829.
9. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-296.
10. Lee PL, Wang JH, Tung HD, et al. A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg 2004;98:367-372.
11. Wang JT, Wang TH, Lin JT, et al. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol 1995;10:454-458.
12. Chang TT, Young KC, Yang YJ, et al. Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver 1996;16:201-206.
13. Lee SD, Chan CY, Wang YJ, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991;13:830-833.
14. Samuel MC, Doherty PM, Bulterys M, et al. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect 2001;127:475-484.
15. Hallinan R, Byrne A, Amin J, et al. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. J Gastroenterol Hepatol 2005;20:1082-1086.
16. Lai SW, Ng KC, Li CI. Descriptive analysis of HBsAg and HCV antibody prevalence in patients receiving health checkups: a hospital-based study. Mid Taiwan J Med 2004;9(suppl 1):s64-s69.
17. Abraham HD, Degli-Esposti S, Marino L. Seroprevalence of hepatitis C in a sample of middle class substance abusers. J Addict Dis 1999;18:77-87.
18. Wada K, Greberman SB, Konuma K, et al. HIV and HCV infection among drug users in Japan. Addiction 1999;94:1063-1069.
19. Habib SE, Lovejoy FH, Aspin C. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern. Southeast Asian J Trop Med Public Health 2001;32:823-834.
20. Herring BL, Tsui R, Peddada L, et al. Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol 2005;79:4340-4346.
21. Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1201-1205.
22. Ko YC, Ho MS, Chiang TA, et al. Tattooing as a risk of hepatitis C virus infection. J Med Virol 1992;38:288-291.